The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis

NCT03129126 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lipella Pharmaceuticals, Inc.